[new] The Journal of Clinical Psychiatry

Page 656

More JCP Articles

Original Research

Buspirone as an Antidote to SSRI-Induced Bruxism in 4 Cases

December 31, 1999

John Michael Bostwick, Michael S. Jaffee

Letter to the Editor

Choreiform Dyskinesia With Acute Onset and Protracted Course Following Fluoxetine Treatment

December 31, 1999

Asker Stig Nielsen, Ole Mors

Original Research

Clinical Features, Psychiatric Comorbidity, and Health-Related Quality of Life in Persons Reporting Compulsive Computer Use Behavior

December 31, 1999

Donald W. Black, Geeta Belsare, Steven Schlosser

Book Review

Clinical Textbook of Addictive Disorders, 2nd ed

December 31, 1999

Peter R. Martin

Letter to the Editor

Deliberate Self-Poisoning Following Fluvoxamine-Neuroleptics Combination

December 31, 1999

Siow-Ann Chong, Andrew Cheong

Book Review

Drug Action in the Central Nervous System

December 31, 1999

Domenic A. Ciraulo

Original Research

Effectiveness of Antipsychotic Therapy in a Naturalistic Setting: A Comparison Between Risperidone, Perphenazine, and Haloperidol

December 31, 1999

Kim C. Coley, Cameron S. Carter, Stacey V. DaPos, et al

Original Research

The Emergence of Social Phobia During Clozapine Treatment and Its Response to Fluoxetine Augmentation

December 31, 1999

Stefano Pallanti, Leonardo Quercioli, Alessandro Rossi, et al

Letter to the Editor

Improved Outcome in Fluvoxamine-Treated Patients With SSRI-Induced Sexual Dysfunction

December 31, 1999

Michael D. Banov

Original Research

Two-Year Maintenance Treatment With Citalopram, 20 mg, in Unipolar Subjects With High Recurrence Rate

December 31, 1999

Linda Franchini, Raffaella Zanardi, Mariangela Gasperini, et al

Brainstorms

Molecular Neurobiology for Practicing Psychiatrists, Part 4: Transferring the Message of Chemical Neurotransmission From Presynaptic Neurotransmitter to Postsynaptic Gene Expression

December 31, 1999

Stephen M. Stahl

Original Research

Multicenter, Placebo-Controlled, Fixed-Dose Study of Citalopram in Moderate-to-Severe Depression

December 31, 1999

John P. Feighner, Kerstin OverÃ¸

« 1 … 654 655 656 657 658 … 748 »

Buspirone as an Antidote to SSRI-Induced Bruxism in 4 Cases

Choreiform Dyskinesia With Acute Onset and Protracted Course Following Fluoxetine Treatment

Clinical Features, Psychiatric Comorbidity, and Health-Related Quality of Life in Persons Reporting Compulsive Computer Use Behavior

Clinical Textbook of Addictive Disorders, 2nd ed

Deliberate Self-Poisoning Following Fluvoxamine-Neuroleptics Combination

Drug Action in the Central Nervous System

Effectiveness of Antipsychotic Therapy in a Naturalistic Setting: A Comparison Between Risperidone, Perphenazine, and Haloperidol

The Emergence of Social Phobia During Clozapine Treatment and Its Response to Fluoxetine Augmentation

Improved Outcome in Fluvoxamine-Treated Patients With SSRI-Induced Sexual Dysfunction

Two-Year Maintenance Treatment With Citalopram, 20 mg, in Unipolar Subjects With High Recurrence Rate

Molecular Neurobiology for Practicing Psychiatrists, Part 4: Transferring the Message of Chemical Neurotransmission From Presynaptic Neurotransmitter to Postsynaptic Gene Expression

Multicenter, Placebo-Controlled, Fixed-Dose Study of Citalopram in Moderate-to-Severe Depression

ELSEWHERE:

FOLLOW US:

More JCP Articles

Buspirone as an Antidote to SSRI-Induced Bruxism in 4 Cases

Choreiform Dyskinesia With Acute Onset and Protracted Course Following Fluoxetine Treatment

Clinical Features, Psychiatric Comorbidity, and Health-Related Quality of Life in Persons Reporting Compulsive Computer Use Behavior

Clinical Textbook of Addictive Disorders, 2nd ed

Deliberate Self-Poisoning Following Fluvoxamine-Neuroleptics Combination

Drug Action in the Central Nervous System

Effectiveness of Antipsychotic Therapy in a Naturalistic Setting: A Comparison Between Risperidone, Perphenazine, and Haloperidol

The Emergence of Social Phobia During Clozapine Treatment and Its Response to Fluoxetine Augmentation

Improved Outcome in Fluvoxamine-Treated Patients With SSRI-Induced Sexual Dysfunction

Two-Year Maintenance Treatment With Citalopram, 20 mg, in Unipolar Subjects With High Recurrence Rate

Molecular Neurobiology for Practicing Psychiatrists, Part 4: Transferring the Message of Chemical Neurotransmission From Presynaptic Neurotransmitter to Postsynaptic Gene Expression

Multicenter, Placebo-Controlled, Fixed-Dose Study of Citalopram in Moderate-to-Severe Depression

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles